Top Markets
Coin of the day
Kringle Pharma, Inc. Kringle Pharma, Inc.

Kringle Pharma, Inc.

4884
Rank in Stocks #29210
Kringle Pharma, Inc. specializes in the innovation, production, and... Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.
Share Price
$2.77
Market Cap
$22.40M
Change (1 day)
-0.93%
Change (1 year)
-17.48%
Country
JP
Trade Kringle Pharma, Inc. (4884)

Category

Operating Margin for Kringle Pharma, Inc. (4884)
Operating Margin as of 2026 TTM: 0.00%
According to Kringle Pharma, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Kringle Pharma, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.